Structures by: Shan N.
Total: 39
CTA/An
C9H12O6,C2H3N1
New Journal of Chemistry (2003) 27, 2 365
a=6.8309(5)Å b=16.0470(13)Å c=22.8001(11)Å
α=90.00° β=90.00° γ=90.00°
CTA/APY
C4H5N3,C9H12O6
New Journal of Chemistry (2003) 27, 2 365
a=5.6250(2)Å b=23.8851(18)Å c=11.2217(9)Å
α=90.00° β=100.109(5)° γ=90.00°
CTA/oPh/2MeOH
C9H12O6,C12H8N2,C2H8O2
New Journal of Chemistry (2003) 27, 2 365
a=8.8501(5)Å b=11.0316(8)Å c=11.8635(7)Å
α=90.185(3)° β=95.174(4)° γ=92.475(4)°
CTA/HMTA
C9H12O6,C6H12N4
New Journal of Chemistry (2003) 27, 2 365
a=10.9547(4)Å b=14.4867(6)Å c=10.4289(4)Å
α=90.00° β=93.987(2)° γ=90.00°
Tadalafil methylparaben
C22H19N3O4,C8H8O3
CrystEngComm (2012) 14, 7 2377
a=9.4455(3)Å b=7.8767(2)Å c=17.2532(5)Å
α=90.00° β=98.352(2)° γ=90.00°
Tadalafil hydrocinnamic acid
C22H19N3O4,C9H10O2
CrystEngComm (2012) 14, 7 2377
a=9.5476(12)Å b=8.1881(10)Å c=16.673(2)Å
α=90.00° β=96.305(9)° γ=90.00°
Tadalafil propylparaben
C22H19N3O4,C10H12O3
CrystEngComm (2012) 14, 7 2377
a=9.3357(2)Å b=8.3056(2)Å c=17.3542(5)Å
α=90.00° β=90.854(2)° γ=90.00°
Chlorobis(nicotinamide-κN)(1,4,7-trithiacyclononane-κ^3^S)ruthenium(II) hexafluorophosphate monohydrate
C18H24ClN4O2RuS31,F6P1,H2O
Acta Crystallographica Section E (2004) 60, 5 m662-m663
a=12.9575(15)Å b=9.8190(11)Å c=20.974(3)Å
α=90.00° β=101.483(2)° γ=90.00°
Quinolinium Fumarate
C9H8N1,C4H3O41
Acta Crystallographica Section E (2003) 59, 4 o397-o398
a=22.5838(5)Å b=3.72730(10)Å c=13.2912(5)Å
α=90.00° β=90.00° γ=90.00°
2-(p-Nitrophenoxy)terahydropyran
C11H13NO4
Acta Crystallographica Section E (2004) 60, 11 o1923-o1924
a=7.47720(10)Å b=21.9462(4)Å c=6.78280(10)Å
α=90.00° β=102.4910(10)° γ=90.00°
Indomethacin methyl ester
C20H18ClNO4
Acta Crystallographica Section E (2004) 60, 4 o508-o509
a=19.0206(5)Å b=4.83260(10)Å c=19.3092(8)Å
α=90.00° β=97.7390(10)° γ=90.00°
Poly[[tetra-μ~2~-aqua-diaqua-μ~2~-2,5-dibenzoylterephthalato dipotassium(I)] dihydrate]
C24H22O12,2H2O
Acta Crystallographica Section E (2006) 62, 2 m201-m203
a=6.153(2)Å b=8.455(3)Å c=13.769(4)Å
α=69.441(11)° β=79.673(13)° γ=87.265(14)°
NTA--1,10-phenanthroline--water (1/1/1)
C6H8NO6,C12H9N2,H2O
Acta Crystallographica Section E (2001) 57, 8 o811-o813
a=22.7045(6)Å b=11.1044(3)Å c=14.2366(2)Å
α=90.00° β=90.00° γ=90.00°
P-Xylene-α,α-diol
C8H10O2
Acta Crystallographica Section E (2001) 57, 12 o1233-o1234
a=4.8118(3)Å b=15.4697(14)Å c=9.7712(8)Å
α=90.00° β=101.798(5)° γ=90.00°
Acridine--isophthalic acid
C13H10N11,C8H5O41
Acta Crystallographica Section E (2001) 57, 10 o945-o946
a=8.5196(9)Å b=9.1440(10)Å c=11.386(4)Å
α=69.41(2)° β=89.440(10)° γ=84.220(10)°
Diphenic acid--acridine(1/1)
C14H10O4,C14H9O41,C13H9N,C13H10N1
Acta Crystallographica Section E (2001) 57, 11 o1075-o1077
a=14.461(3)Å b=15.863(3)Å c=19.166(3)Å
α=90.00° β=108.98(2)° γ=90.00°
4,7-phenanthroline
C12H8N2
Acta Crystallographica Section E (2001) 57, 2 o145-o146
a=19.141(4)Å b=3.8417(4)Å c=11.564(2)Å
α=90.00° β=90.00° γ=90.00°
Potassium 2-benzoylbenzoate dihydrate
K,C14H9O3,2H2O1
Acta Crystallographica, Section E (2006) 62, 2 o427-o428
a=10.391(4)Å b=7.771(3)Å c=33.314(13)Å
α=90.00° β=90.00° γ=90.00°
1,4-Diacetylbenzene
C10H10O2
Acta Crystallographica Section E (2006) 62, 4 o1582-o1583
a=12.699(3)Å b=5.4604(11)Å c=12.950(3)Å
α=90.00° β=114.07(3)° γ=90.00°
C18H26ClF6N4O3PRuS3
C18H26ClF6N4O3PRuS3
Inorganic Chemistry (2008) 47, 11551-11560
a=12.9575(15)Å b=9.8190(11)Å c=20.974(3)Å
α=90.00° β=101.483(2)° γ=90.00°
C18H28BClF4N4O4RuS3
C18H28BClF4N4O4RuS3
Inorganic Chemistry (2008) 47, 11551-11560
a=12.952(3)Å b=9.763(2)Å c=20.645(4)Å
α=90.00° β=101.69(3)° γ=90.00°
C18H24ClF6N4O2PRuS3
C18H24ClF6N4O2PRuS3
Inorganic Chemistry (2008) 47, 11551-11560
a=10.3214(15)Å b=15.484(2)Å c=16.007(2)Å
α=90.00° β=90.00° γ=90.00°
C20H28F12N4O2P2RuS4
C20H28F12N4O2P2RuS4
Inorganic Chemistry (2008) 47, 11551-11560
a=15.641(3)Å b=9.6230(16)Å c=21.087(3)Å
α=90.00° β=90.00° γ=90.00°
C23H35F12N5O4P2RuS4
C23H35F12N5O4P2RuS4
Inorganic Chemistry (2008) 47, 11551-11560
a=10.0122(4)Å b=15.7691(7)Å c=22.5666(10)Å
α=90.00° β=92.1550(10)° γ=90.00°
C26H32F12N4O2P2RuS4
C26H32F12N4O2P2RuS4
Inorganic Chemistry (2008) 47, 11551-11560
a=21.842(4)Å b=34.924(6)Å c=21.160(4)Å
α=90.00° β=90.00° γ=90.00°
C25H21N3O7S2
C25H21N3O7S2
Crystal Growth & Design (2010) 10, 10 4401
a=6.938(3)Å b=11.997(5)Å c=15.107(6)Å
α=112.838(5)° β=92.889(6)° γ=95.816(6)°
C19H21N3O8S2
C19H21N3O8S2
Crystal Growth & Design (2010) 10, 10 4401
a=7.181(2)Å b=8.439(3)Å c=18.364(6)Å
α=80.737(4)° β=85.464(4)° γ=70.865(4)°
C32H32N6O13S4
C32H32N6O13S4
Crystal Growth & Design (2010) 10, 10 4401
a=7.278(2)Å b=8.550(2)Å c=15.150(4)Å
α=84.115(3)° β=81.617(4)° γ=70.489(3)°
C32H30N6O12S4
C32H30N6O12S4
Crystal Growth & Design (2010) 10, 10 4401
a=7.145(5)Å b=8.475(5)Å c=15.088(9)Å
α=82.250(9)° β=81.368(9)° γ=70.519(9)°
C32H32N6O12S4
C32H32N6O12S4
Crystal Growth & Design (2010) 10, 10 4401
a=7.2315(4)Å b=8.4994(5)Å c=14.9383(8)Å
α=82.741(4)° β=80.061(3)° γ=70.313(4)°
4
C9H7Cl2N5,C6H6N2O1,H2O1
Crystal Growth & Design (2010) 10, 1 394
a=7.3047(6)Å b=8.4939(7)Å c=14.6964(12)Å
α=105.081(5)° β=90.580(5)° γ=95.244(5)°
9
C9H7Cl2N5,C2H8O2
Crystal Growth & Design (2010) 10, 1 394
a=19.326(4)Å b=17.584(3)Å c=8.2698(15)Å
α=90.00° β=97.820(3)° γ=90.00°
10
C9H7Cl2N5,C2H6O,H2O
Crystal Growth & Design (2010) 10, 1 394
a=7.1308(14)Å b=8.3566(16)Å c=24.018(5)Å
α=90.00° β=94.565(3)° γ=90.00°
6
C9H8Cl2N5,C3H4O2
Crystal Growth & Design (2010) 10, 1 394
a=13.068(3)Å b=7.498(2)Å c=14.069(3)Å
α=90.00° β=96.755(4)° γ=90.00°
7
C22H20Cl4N10O5
Crystal Growth & Design (2010) 10, 1 394
a=10.728(2)Å b=10.2003(19)Å c=12.721(2)Å
α=90.00° β=107.634(13)° γ=90.00°
8
C9H8Cl2N5,C6H4NO2,C2H8O2
Crystal Growth & Design (2010) 10, 1 394
a=7.648(3)Å b=15.863(6)Å c=16.803(7)Å
α=90.00° β=90.072(6)° γ=90.00°
5
C9H8Cl2N5,C7H5N1O3S1
Crystal Growth & Design (2010) 10, 1 394
a=18.447(5)Å b=6.954(2)Å c=14.762(4)Å
α=90.00° β=107.978(4)° γ=90.00°
1
C9H7Cl2N5,C8H8O3
Crystal Growth & Design (2010) 10, 1 394
a=5.2729(9)Å b=14.330(3)Å c=23.822(4)Å
α=90.00° β=92.795(3)° γ=90.00°
2
C9H7Cl2N5,C8H8O3
Crystal Growth & Design (2010) 10, 1 394
a=8.8957(18)Å b=11.409(2)Å c=12.040(2)Å
α=107.05(3)° β=102.10(3)° γ=112.50(3)°